BERLIN — The German government is taking a 23% stake in a German company working on a potential vaccine for the coronavirus.
Economy Minister Peter Altmaier said Monday that the state-owned KfW development bank will buy 300 million euros ($337 million) in CureVac shares. He said the aim is to give CureVac “financial security.”
Altmaier stressed the government’s desire to keep key companies in various sectors in Germany.
In March, Chancellor Angela Merkel’s chief of staff, Helge Braun, said that German officials had had “very intensive contact” with Curevac and that there had been “thoughts of enticing it to the United States.” He didn’t elaborate on the nature of the U.S. interest.